搜索临床试验以：89Zr-TLX250 (89Zirconium-TLX250) PET/CT
总计716个结果
-
Telix Pharmaceuticals (Innovations) Pty Limited完全的
-
Telix International Pty Ltd完全的
-
Telix International Pty LtdGrand Pharmaceutical (China) Co., Ltd.完全的
-
Institut Cancerologie de l'OuestATONCO完全的
-
Institut Cancerologie de l'OuestTelix Pharmaceutical; SIRIC ILIAD招聘中
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, Germany招聘中
-
Telix International Pty Ltd招聘中软组织肉瘤 | 宫颈癌 | 鼻咽癌 | 小细胞肺癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 食道癌 | 多形性胶质母细胞瘤 | 非小细胞肺癌 | 胆管癌 | 上皮性卵巢癌 | 头颈部鳞状细胞癌 | 胰腺导管腺癌美国
-
Jonsson Comprehensive Cancer CenterTelix Pharmaceuticals (Innovations) Pty Limited尚未招聘透明细胞肾细胞癌 | III期肾细胞癌 | 肉瘤样肾细胞癌 | IV 期肾细胞癌 | II期肾细胞癌美国
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.完全的
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University完全的
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaA终止
-
Boehringer Ingelheim招聘中黑色素瘤 | 非小细胞肺癌 (NSCLC) | 头颈部鳞状细胞癌 (HNSCC)荷兰
-
South Metropolitan Health ServiceTelix Pharmaceuticals (Innovations) Pty Limited完全的
-
Radboud University Medical CenterABX CRO; Telix International Pty Ltd完全的
-
University of Saskatchewan招聘中
-
University of Alabama at Birmingham招聘中
-
ImaginAb, Inc.招聘中黑色素瘤 | 肾细胞癌 | 非小细胞肺癌 | 未明确的默克尔细胞癌美国, 澳大利亚, 比利时, 荷兰, 瑞士, 英国
-
GlaxoSmithKlinePRA Health Sciences for clinical study conduct.完全的
-
Radboud University Medical CenterMerck KGaA, Darmstadt, Germany完全的
-
Université de SherbrookeEli Lilly and Company; Chorus Wellness Inc.; AL-S Pharma AG招聘中
-
University Medical Center GroningenGenentech, Inc.; Amsterdam UMC, location VUmc完全的
-
The First Affiliated Hospital of Soochow UniversityMITRO Biotech Co., Ltd.未知
-
Radboud University Medical CenterImaginAb, Inc.招聘中
-
Memorial Sloan Kettering Cancer Center主动，不招人
-
Amsterdam UMC, location VUmcFoundation for the National Institutes of Health尚未招聘
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Karolinska University Hospital招聘中
-
BioNTech Research & Development, Inc.SciQuus Oncology终止